ICUI Relative Valuation
ICUI's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, ICUI is overvalued; if below, it's undervalued.
Historical Valuation
ICU Medical Inc (ICUI) is now in the Undervalued zone, suggesting that its current forward PS ratio of 1.51 is considered Undervalued compared with the five-year average of 6.51. The fair price of ICU Medical Inc (ICUI) is between 148.41 to 265.21 according to relative valuation methord. Compared to the current price of 130.53 USD , ICU Medical Inc is Undervalued By 12.05%.
Relative Value
Fair Zone
148.41-265.21
Current Price：130.53
12.05%
Undervalued
Trailing
Forward
P/E
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
1.61
P/B
Median3y
1.69
Median5y
2.14
3.94
FCF Yield
Median3y
1.21
Median5y
2.02
Competitors Valuation Multiple
The average P/S ratio for ICUI's competitors is 3.13, providing a benchmark for relative valuation. ICU Medical Inc Corp (ICUI) exhibits a P/S ratio of 1.51, which is -51.68% above the industry average. Given its robust revenue growth of 6.71%, this premium appears unsustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
Revenue Growth
Market Cap
People Also Watch
FAQ
Is ICU Medical Inc (ICUI) currently overvalued or undervalued?
What is ICU Medical Inc (ICUI) fair value?
How does ICUI's valuation metrics compare to the industry average?
What is the current P/B ratio for ICU Medical Inc (ICUI) as of Jul 08 2025?
What is the current FCF Yield for ICU Medical Inc (ICUI) as of Jul 08 2025?
What is the current Forward P/E ratio for ICU Medical Inc (ICUI) as of Jul 08 2025?